Introduction
Current Problem: A third of the total world population does not have access to proper medication, which has resulted in increased mortality rates. In parts such as Africa and Asia, half of the population lacks access to essential medications.
Area of Focus: This paper will focus on the role of pharmaceutical companies in developing a solution to the issue of lack of essential medicine to 30% of the world’s population.
Thesis statement
The paper examines the key demographics about access to medication and analyses the various strategies that pharmaceutical companies can use to ensure that the one-third of the world’s population has access to all essential medicines.
Supporting points
Pharmaceutical companies can work together with world organizations, such as UN and WHO, to ensure that even people in remote parts of the world have access to essential medicines. Collaborations may take different forms including sharing costs in production and transport of medicine (Brown & Bussell, 2011).
Pharmaceutical companies can work together with local organizations and groups to ensure that people in third world countries have access to life-saving medicine. Such cooperation may involve sharing of knowledge on how various medications work as well as ways to develop some medications (Kessel, 2014).
Concluding sentence
Collaborating with international and regional health bodies would ensure that pharmaceutical companies reach people from even the most remote areas in the world. This collaboration would ensure an increase in access to life-saving medication.
Collaboration with national and regional governments would ensure that people in poor areas have access to all essential medications.
Supporting Points
Pharmaceutical companies can work governments to ensure that every country has enough access to medications. Collaboration may take the form of educating health officials on the different ways of administering different medicines as well as education of the newest and most effective medicines to use (Health Research Institute, 2015).
Pharmaceutical companies can also give discounts to governments who buy medicine in bulk. Such discounts would allow governments to stock all hospitals and health centers with essential medications (Schultz, 2012).
Concluding sentence
Collaborating with governments would ensure that public health facilities have both the knowledge of the different medicines and enough medication for every individual visiting the hospitals.
The introduction of distribution channels in different parts of the world would promote access to essential medicine.
Supporting Points
The opening of distribution channels would result in pharmaceutical companies selling medicines at lower prices as transport costs would have been eliminating (McCabe, 2009).
The opening of distribution channels in different areas would also ensure that drugs are always available in case an emergency occurs (McCabe, 2009).
Opening of distribution channels will also allow a sharing of skills and knowledge with local drug production companies; therefore, allowing continuous production
Concluding Sentence
The introduction of distribution channels in different regions of the world would allow every country to have equal access to essential medications.
Conclusion
Pharmaceutical companies play a huge role in ensuring access to essential medications by many people. Ensuring that people have access to life-saving medication requires collaborations between pharmaceutical companies and international and local health bodies. Collaboration with national governments and public health departments would also ensure that every individual has access to essential medications. The opening of regional distribution points would also ensure that every individual has access to the right medication.
Bibliography
Brown, M. T. & Bussell, J. K., 2011. Medication Adherence: WHO Cares?. Mayo Clinic Proceedings, 86(4), pp. 304-314.
Health Research Institute, 2015. 21st Century Pharmaceutical Collaboration: The Value Convergence. [Online] Available at https://www.pwc.se/sv/bioteknik/assets/21st-century-pharmaceutical-collaboration.pdf
Kessel, M., 2014. Private Sector Pharmaceutical Supply and. Nature Biotechnology, Volume 32, pp. 983-990.
McCabe, A., 2009. Private Sector Pharmaceutical Supply and Distribution Chains. Health Systems for Outcome Publications, pp. 9-54.
Schultz, D., 2012. Drug companies fend off Competition from generics by offering discount coupons. [Online] Available at: https://www.washingtonpost.com/national/health-science/drug-companies-fend-off-competition-from-generics-by-offering-discount-coupons/2012/10/01/c7a393be-f05f-11e1-ba17-c7bb037a1d5b_story.html
